Article metrics
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced hepatocellular carcinoma